NCT03000374 Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery Status COMPLETED Phase PHASE2
NCT02994927 A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Status COMPLETED Phase PHASE3
NCT02993120 Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States Status COMPLETED Phase N/A
NCT02990104 First Report, Five Years Experience of the Acute Leukemia Work Group Status UNKNOWN Phase N/A
NCT02986139 Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02983097 Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP Status TERMINATED Phase PHASE1/PHASE2
NCT02970747 Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients Status COMPLETED Phase N/A
NCT02969837 Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02961881 A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT02939183 Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02937701 Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab Status COMPLETED Phase PHASE3
NCT02922192 Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis Status COMPLETED Phase N/A
NCT02922179 Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics Status COMPLETED Phase N/A
NCT02921191 Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated Status COMPLETED Phase N/A
NCT02910557 Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection Status COMPLETED Phase N/A
NCT02910063 Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL Status COMPLETED Phase PHASE2/PHASE3